Denali Therapeutics (Series B)

Funding Details

Awarder

Inbox

Date Award

August 26, 2016

Vertical

Biotechnology

Funding URL

View Funding Page

Funding Amount:

$130,000,000

---

Company Info

Founders

Marc Tessier-Lavigne, Ryan Watts, Alex Schuth

Company Description

Denali Therapeutics is a privately held biotechnology company focused on the discovery and development of therapies for patients with neurodegenerative disease, including Alzheimer's disease, Parkinson's disease, ALS and others.

Market

Neurodegenerative diseases

Location

San Francisco, California, USA

Coinvestors

Alaska Permanent Fund, ARCH Venture Partners, Baillie Gifford, Fidelity Biosciences, Flagship Ventures

---

Links

• Website